476 related articles for article (PubMed ID: 11464184)
1. Dense inflammation does not mask residual primary basal cell carcinoma during Mohs micrographic surgery.
Katz KH; Helm KF; Billingsley EM; Maloney ME
J Am Acad Dermatol; 2001 Aug; 45(2):231-8. PubMed ID: 11464184
[TBL] [Abstract][Full Text] [Related]
2. Innovative 19-minute rapid cytokeratin immunostaining of nonmelanoma skin cancer in Mohs micrographic surgery.
Cherpelis BS; Turner L; Ladd S; Glass LF; Fenske NA
Dermatol Surg; 2009 Jul; 35(7):1050-6. PubMed ID: 19469800
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical stains in Mohs surgery: a review.
Stranahan D; Cherpelis BS; Glass LF; Ladd S; Fenske NA
Dermatol Surg; 2009 Jul; 35(7):1023-34. PubMed ID: 19397647
[TBL] [Abstract][Full Text] [Related]
4. Histological evaluation of residual basal cell carcinoma after shave biopsy prior to Mohs micrographic surgery.
Alcalay J; Alkalay R
J Eur Acad Dermatol Venereol; 2011 Jul; 25(7):839-41. PubMed ID: 21054570
[TBL] [Abstract][Full Text] [Related]
5. The use of antidesmoglein stains in Mohs micrographic surgery. A potential aid for the differentiation of basal cell carcinoma from horizontal sections of the hair follicle and folliculocentric basaloid proliferation.
Krunic AL; Garrod DR; Viehman GE; Madani S; Buchanan MD; Clark RE
Dermatol Surg; 1997 Jun; 23(6):463-8. PubMed ID: 9217798
[TBL] [Abstract][Full Text] [Related]
6. Incidence of residual basal cell carcinoma in patients who appear tumor free after biopsy.
Holmkvist KA; Rogers GS; Dahl PR
J Am Acad Dermatol; 1999 Oct; 41(4):600-5. PubMed ID: 10495384
[TBL] [Abstract][Full Text] [Related]
7. Does the dual use of toluidine blue and hematoxylin and eosin staining improve basal cell carcinoma detection by Mohs surgery trainees?
Tehrani H; May K; Morris A; Motley R
Dermatol Surg; 2013 Jul; 39(7):995-1000. PubMed ID: 23465179
[TBL] [Abstract][Full Text] [Related]
8. Residual skin cancer after preoperative biopsy: evaluation by Mohs micrographic surgery.
Alcalay J; Alkalay R; Hazaz B
Int J Dermatol; 2004 Jun; 43(6):456-8. PubMed ID: 15186232
[TBL] [Abstract][Full Text] [Related]
9. Micrographic controlled surgery of basal cell carcinomas: rapid lump examination in comparison with haematoxylin and eosin-stained paraffin sections.
Peters N; Schubert M; Geppert JP; Moehrle M
Br J Dermatol; 2019 Aug; 181(2):399-400. PubMed ID: 30729494
[No Abstract] [Full Text] [Related]
10. Adjuvant cytokeratin staining in Mohs micrographic surgery for basal cell carcinoma.
Smeets NW; Stavast-Kooy AJ; Krekels GA; Daemen MJ; Neumann HA
Dermatol Surg; 2003 Apr; 29(4):375-7. PubMed ID: 12656816
[TBL] [Abstract][Full Text] [Related]
11. Current progress of immunostains in Mohs micrographic surgery: a review.
Thosani MK; Marghoob A; Chen CS
Dermatol Surg; 2008 Dec; 34(12):1621-36. PubMed ID: 19018832
[TBL] [Abstract][Full Text] [Related]
12. Randomized, controlled surgical trial of preoperative tumor curettage of basal cell carcinoma in Mohs micrographic surgery.
Huang CC; Boyce S; Northington M; Desmond R; Soong SJ
J Am Acad Dermatol; 2004 Oct; 51(4):585-91. PubMed ID: 15389195
[TBL] [Abstract][Full Text] [Related]
13. Risk of synchronous and metachronous second nonmelanoma skin cancer when referred for Mohs micrographic surgery.
Schinstine M; Goldman GD
J Am Acad Dermatol; 2001 Mar; 44(3):497-9. PubMed ID: 11209121
[TBL] [Abstract][Full Text] [Related]
14. Basal cell carcinoma: rapid techniques using cytokeratin markers to assist treatment by micrographic (Mohs') surgery.
Ramnarain ND; Walker NP; Markey AC
Br J Biomed Sci; 1995 Sep; 52(3):184-7. PubMed ID: 8527995
[TBL] [Abstract][Full Text] [Related]
15. Use of ex vivo confocal scanning laser microscopy during Mohs surgery for nonmelanoma skin cancers.
Chung VQ; Dwyer PJ; Nehal KS; Rajadhyaksha M; Menaker GM; Charles C; Jiang SB
Dermatol Surg; 2004 Dec; 30(12 Pt 1):1470-8. PubMed ID: 15606734
[TBL] [Abstract][Full Text] [Related]
16. Quantitative and Qualitative Comparison of Two Hematoxylin and Eosin Staining Protocols for Mohs Micrographic Surgery: A Pilot Study.
Surprenant D; Reserva J; Krol C; Alam M
Dermatol Surg; 2021 Nov; 47(11):1502-1504. PubMed ID: 34699441
[No Abstract] [Full Text] [Related]
17. Mohs micrographic surgery: a synopsis.
Stone JL
Hawaii Med J; 1993 May; 52(5):134-9. PubMed ID: 8320092
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical techniques in Mohs micrographic surgery: their potential use in the detection of neoplastic cells masked by inflammation.
Jimenez FJ; Grichnik JM; Buchanan MD; Clark RE
J Am Acad Dermatol; 1995 Jan; 32(1):89-94. PubMed ID: 7529778
[TBL] [Abstract][Full Text] [Related]
19. Economic impact of preoperative curettage before Mohs micrographic surgery for basal cell carcinoma.
Lee DA; Ratner D
Dermatol Surg; 2006 Jul; 32(7):916-22; discussion 922-3. PubMed ID: 16875474
[TBL] [Abstract][Full Text] [Related]
20. Pitfalls in frozen section interpretation in Mohs micrographic surgery.
Hitchcock MG; Leshin B; White WL
Adv Dermatol; 1997; 13():427-62. PubMed ID: 9551151
[No Abstract] [Full Text] [Related]
[Next] [New Search]
